En
En
Fr
Fr
De
De
It
It
Es
Es
Cn
Cn
16 YEARS OF INTERNATIONAL CLINICAL EXPERIENCE IN TRANSPLANTATION OF HUMAN EMBRYONIC/FETAL STEM CELLS
THE WORLDS LARGEST CLINICAL EXPERIENCE IN EMBRYONIC STEM CELL TRANSPLANTATION FOR VARIOUS DISEASES AND CONDITIONS.

Home
About EmCell
EmCell Therapy
Our Experience
List of Diseases:
Oncology
Diabetes Mellitus
Nervous System
Aging Problems
Immune Deficiency
Endoscopic Treatment of Liver Diseases
Investment Projects
Clinical Trials
Congresses and Conferences
Video and other materials
Mail Center

Welcome to Emcell

Practical aim:
- to render our unique medical aid,
- to spread Embryonic Stem Cell Transplantation methods worldwide,
- to promote our Patents, American, European

Open for medical, scientific and business cooperation.

Professor Alexandr Smikodub, M.D., Ph.D
Inventor of the method of treatment with
embryonic stem cells.
Head of Cell Therapy Clinic of
National Medical University


Contact e-mail:

infocenter@emcell.com
- general
emcellclinic@emcell.com - EmCell Clinic, Prof.A.Smikodub
Telephone: +38 067 503 0926
 


IMPORTANT MESSAGE

First ever transplantation of hematopoietic stem cells for diabetes mellitus (DM) was performed by Prof. O.I. Smikodub and his group on December 2, 1991 in the I Medical Department of Kiev Municipal Clinical Hospital No.4, Ukraine.

Hematopoietic stem cells (HSC) were isolated from the liver of 8 weeks old embryonic cadaver and transplanted to patient P. (born in 1960) four months after onset of the disease (type 1 diabetes mellitus).  In the following 3 months, insulin intake decreased by 55% and was maintained at this level for 9 months.  This discovery fostered clinical study of hematopoietic embryonic stem cells harvested from liver, spleen, and bone marrow of 5-8 weeks old embryonic cadavers in types 1 and 2 DM, in different clinical courses of DM and its complications.  The results were stunning: decrease of insulin intake by 30-70%, discontinuation of insulin therapy, decrease of the doses of oral antiglycemic medications, lower hyperinsulinism, normalization of endogenic insulin and C-peptide.

more

 

News
2008-09-25
Prof. Alexander I. Smikodub attended European Congress on Anti-Aging and

Prof. Alexander I. Smikodub attended European Congress on Anti-Aging and Aesthetic Medicine held in Dusseldorf, Germany on September 11-14, 2008 as ...
  Other news
 
Publications

25. Application Of Embryonic Cell Suspensions In Patients With Solid Tumors Before Initiation Of Radical Treatment

Smikodub O.
Cell Therapy Clinic of National Medical University and Embryonic Tissues Center EmCell

Patients with solid tumors and complications that made initiations of anti-cancer treatment impossible, were ...
  Other publications
 
Patents

Medicinal preparation based on fetal cell suspension having immune substituting effect for patients with acquired immune ...
   
 
Copyright © 1999-2008 EmCell.com